Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung Transplantation
Clinical trial NCT03072589 · UNKNOWN
Trial details
- NCT number
- NCT03072589
- Sponsor
- Christine Lau, MD
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-30
- Primary completion
- 2021-08-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.